Gujarat Themis Biosyn (BOM:506879) Debt-to-Equity : 0.02 (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Gujarat Themis Biosyn Debt-to-Equity?

Gujarat Themis Biosyn's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹18 Mil. Gujarat Themis Biosyn's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹16 Mil. Gujarat Themis Biosyn's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₹2,234 Mil. Gujarat Themis Biosyn's debt to equity for the quarter that ended in Sep. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Gujarat Themis Biosyn's Debt-to-Equity or its related term are showing as below:

BOM:506879' s Debt-to-Equity Range Over the Past 10 Years
Min: -6.73 Med: 0.02 Max: 3.85
Current: 0.02

During the past 13 years, the highest Debt-to-Equity Ratio of Gujarat Themis Biosyn was 3.85. The lowest was -6.73. And the median was 0.02.

BOM:506879's Debt-to-Equity is ranked better than
92.52% of 829 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs BOM:506879: 0.02

Gujarat Themis Biosyn Debt-to-Equity Historical Data

The historical data trend for Gujarat Themis Biosyn's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Themis Biosyn Debt-to-Equity Chart

Gujarat Themis Biosyn Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.19

0.07

0.01

Gujarat Themis Biosyn Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															0.01	N/A	0.01	N/A	0.02

Competitive Comparison of Gujarat Themis Biosyn's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gujarat Themis Biosyn's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Gujarat Themis Biosyn's Debt-to-Equity falls into.

Gujarat Themis Biosyn Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Gujarat Themis Biosyn's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(15.437	+	12.247)	/	2013.761
	=	0.01

Gujarat Themis Biosyn's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.225	+	15.74)	/	2234.384
	=	0.02

Gujarat Themis Biosyn (BOM:506879) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Gujarat Themis Biosyn Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Gujarat Themis Biosyn's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Gujarat Themis Biosyn Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Themis Biosyn Ltd (BOM:506879) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104

Website

https://www.gtbl.in

Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.

Gujarat Themis Biosyn Headlines

No Headlines